A role for the receptor tyrosine kinase, Axl, in squamous cell carcinoma invasion and survival

被引：0
|
作者：
Papadakis, E. S. [1 ]
Vyas, J. J. [1 ]
Storey, A. [2 ]
O'Toole, E. A. [1 ]
机构：
[1] Barts & London SMD, Ctr Cutaneous Res, London, England
[2] Univ Oxford, Weatherall Inst Mol Med, Oxford, England
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2008年 / 128卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
219
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [41] The neurotrophic tyrosine kinase receptor 1 (TrkA) is overexpressed in oesophageal squamous cell carcinoma
    Griffin, Nathan
    Gao, Fangfang
    Jobling, Phillip
    Oldmeadow, Christopher
    Wills, Vanessa
    Walker, Marjorie M.
    Faulkner, Sam
    Hondermarck, Hubert
    PATHOLOGY, 2021, 53 (04) : 470 - 477
  • [42] Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
    Pillai, Mohan Shankar Gopinatha
    Aiswarya, Sreekumar U.
    Keerthana, Chenicheri K.
    Rayginia, Tennyson P.
    Anto, Ruby John
    ISCIENCE, 2023, 26 (06)
  • [43] Receptor Tyrosine Kinase Profiles and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma
    Perrone, F.
    Cortelazzi, B.
    Gloghini, A.
    Bossi, P.
    Gualeni, A. V.
    Licitra, L.
    Pilotti, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 172 - 172
  • [44] Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma
    Cortelazzi, Barbara
    Verderio, Paolo
    Ciniselli, Chiara Maura
    Pizzamiglio, Sara
    Bossi, Paolo
    Gloghini, Annunziata
    Gualeni, Ambra V.
    Volpi, Chiara C.
    Locati, Laura
    Pierotti, Marco A.
    Licitra, Lisa
    Pilotti, Silvana
    Perrone, Federica
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2015, 44 (09) : 734 - 745
  • [45] Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma
    Markovic, Ana
    Chung, Christine H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1149 - 1159
  • [46] Axl receptor tyrosine kinase is a novel target of apigenin for the inhibition of cell proliferation
    Kim, Kyung-Chan
    Choi, Eun-Ha
    Lee, Chuhee
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 (02) : 592 - 598
  • [47] AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
    Schmid, Edward T.
    Pang, Iris K.
    Silva, Eugenio A. Carrera
    Bosurgi, Lidia
    Miner, Jonathan J.
    Diamond, Michael S.
    Iwasaki, Akiko
    Rothlin, Carla V.
    ELIFE, 2016, 5
  • [48] Axl receptor tyrosine kinase expression in breast cancer
    D'Alfonso, Timothy M.
    Hannah, Jeffrey
    Chen, Zhengming
    Liu, Yifang
    Zhou, Pengbo
    Shin, Sandra J.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (08) : 690 - 696
  • [49] Axl receptor tyrosine kinase is a regulator of apolipoprotein E
    Zhao, Wenchen
    Fan, Jianjia
    Kulic, Iva
    Koh, Cheryl
    Clark, Amanda
    Meuller, Johan
    Engkvist, Ola
    Barichievy, Samantha
    Raynoschek, Carina
    Hicks, Ryan
    Maresca, Marcello
    Wang, Qi
    Brown, Dean G.
    Lok, Alvin
    Parro, Cameron
    Robert, Jerome
    Chou, Hsien-Ya
    Zuhl, Andrea M.
    Wood, Michael W.
    Brandon, Nicholas J.
    Wellington, Cheryl L.
    MOLECULAR BRAIN, 2020, 13 (01)
  • [50] Determinants for transformation induced by the Axl receptor tyrosine kinase
    Andreas Burchert
    Eyal C Attar
    Patrick McCloskey
    Yih-Woei C Fridell
    Edison T Liu
    Oncogene, 1998, 16 : 3177 - 3187
12345